Accelerated ageing calculator

Why You Can Predict Years of Shelf Life in Weeks

Most chemical and biological degradation reactions accelerate predictably with heat. Run a product at 55°C instead of 25°C and the degradation that would take two years at storage temperature might complete in a matter of weeks at the elevated test temperature. That’s the entire premise of accelerated ageing: use temperature as a time machine, let the chemistry play out fast, and then reverse-calculate what the real-world lifespan would be.

It’s used everywhere. Pharmaceutical stability studies under ICH Q1A guidelines, medical device shelf life testing under ISO 11607, food packaging durability, adhesive bond strength, polymer degradation, battery capacity fade — all of them rely on this principle. The question is always: how fast does the relevant failure mechanism proceed at the test temperature, and how does that rate compare to the ambient rate?

The Arrhenius Equation — Core of Every Accelerated Ageing Study

The relationship between temperature and reaction rate was formalised by Svante Arrhenius in 1889. In the context of shelf life prediction, it’s expressed as:

AF = exp[(Ea / R) × (1/T_ambient − 1/T_accelerated)]

where:

• AF = acceleration factor (the multiplier applied to real-time)
• Ea = activation energy in joules per mole (or kJ/mol if R is adjusted)
• R = 8.314 × 10⁻³ kJ/mol·K (universal gas constant)
• T = temperatures in Kelvin (add 273.15 to Celsius)

Real-time equivalent = Study duration × AF.

The 83.14 kJ/mol Default and Where It Comes From

ASTM International’s F1980 standard for medical device accelerated ageing uses 83.14 kJ/mol as the default activation energy when the specific degradation mechanism’s Ea hasn’t been experimentally determined. This value produces a Q10 of approximately 2.0 at around 25°C — meaning the reaction rate roughly doubles for every 10°C temperature increase. It was selected as a conservative, widely applicable default rather than a best-fit for any particular material. If your product’s actual Ea has been measured, always use the measured value instead.

Common measured Ea values range from as low as 40 kJ/mol (some enzymatic reactions, UV degradation) to above 150 kJ/mol (some protein aggregation pathways). The higher the Ea, the larger the acceleration factor for a given temperature difference — and the more compressed the study can be.

A Worked Accelerated Ageing Example

Medical device manufacturer targeting a 3-year (1,095-day) shelf life. Accelerated test at 55°C versus ambient storage at 25°C, using the default Ea of 83.14 kJ/mol.

• T_acc = 55 + 273.15 = 328.15 K
• T_amb = 25 + 273.15 = 298.15 K
• AF = exp[(83.14 / 0.008314) × (1/298.15 − 1/328.15)]
• = exp[10,000 × (0.003354 − 0.003047)]
• = exp[10,000 × 0.000307]
• = exp[3.07] ≈ 21.5×

Study duration needed: 1,095 ÷ 21.5 ≈ 50.9 days — just over 7 weeks at 55°C demonstrates the equivalent of 3 years at 25°C ambient conditions.

This is why accelerated ageing is so valuable for product development timelines. Waiting three years to prove shelf life isn’t practical during a development cycle. Fifty days at elevated temperature is.

Q10 Method vs Arrhenius — When to Use Each

The Q10 method is a simplification: it assumes the reaction rate doubles (Q10 = 2) or multiplies by some other fixed factor for every 10°C increase. The formula is straightforward:

AF = Q10^(ΔT/10)

where ΔT is the temperature difference between accelerated and ambient. It’s faster to apply but less accurate because Q10 isn’t truly constant over large temperature ranges — it’s a local approximation. The Arrhenius equation is more theoretically rigorous and is preferred for formal regulatory submissions.

The two methods agree when the chosen Ea produces the same Q10 as your assumption. At 83.14 kJ/mol and temperatures near 25°C, the Arrhenius method yields a Q10 of approximately 2.0, so the results converge for standard pharmaceutical and device applications.

Limitations and What Accelerated Ageing Cannot Tell You

The Arrhenius model assumes a single dominant degradation mechanism. When multiple mechanisms are active — and they often are in complex products — the acceleration factor applies to only one of them. A plasticiser migration rate and a bacterial spore activation temperature both follow their own Arrhenius kinetics, not the same one. Running a study that accelerates one mechanism may leave another completely unaddressed.

Elevated temperature testing also can’t replicate mechanical stress from handling cycles, humidity cycling effects, or UV exposure ageing. For complete shelf life validation, accelerated thermal ageing is usually combined with real-time ageing studies run in parallel, with the accelerated study used to support initial product release and the real-time data used for definitive expiry date claims.

For regulatory submissions, the ICH Q1A (R2) guideline for pharmaceutical products and ASTM F1980 for medical devices are the primary reference documents. The ICH quality guidelines and ASTM F1980 standard both set out the methodology and study design requirements in detail.

If your accelerated ageing study is part of a product launch that involves analysing financial timelines, our accelerated banking calculator can help model the cost of capital across the development period.

FAQs

What is accelerated ageing in shelf life testing?

Accelerated ageing is a technique where a product is stored at elevated temperature to speed up the degradation reactions that would normally happen over months or years at ambient storage conditions. Using the Arrhenius equation or Q10 factor, the time spent at the elevated temperature is converted into a real-time shelf life equivalent.

What is the acceleration factor in an accelerated ageing study?

The acceleration factor (AF) is the ratio of the degradation rate at the elevated test temperature to the rate at ambient conditions. An AF of 10 means degradation proceeds 10 times faster at the test temperature — so 30 days at the test temperature equals 300 days (about 10 months) at ambient.

What activation energy should I use if I don’t know my product’s Ea?

ASTM F1980 recommends using 83.14 kJ/mol as a default activation energy for medical devices when the specific degradation mechanism’s Ea is unknown. This produces an acceleration factor consistent with a Q10 of approximately 2.0 near 25°C. For pharmaceutical products, ICH guidelines specify study conditions but don’t mandate a specific Ea — experimentally determined values are preferred.

What temperature should I use for accelerated ageing?

ASTM F1980 recommends 55°C as the standard elevated test temperature for medical devices with an ambient reference of 25°C, based on the default Ea. ICH Q1A uses 40°C with 75% relative humidity for pharmaceutical accelerated stability studies. For other product categories, the test temperature should be high enough to produce a meaningful acceleration factor but low enough to avoid triggering alternative degradation mechanisms not active at ambient conditions.

Is accelerated ageing accepted by the FDA and other regulatory agencies?

Yes, for medical devices following ASTM F1980 and for pharmaceutical stability data generated under ICH Q1A. Regulatory bodies accept accelerated ageing data to support initial shelf life claims, but they typically require concurrent real-time ageing studies for definitive expiry date claims — particularly for products with claims extending beyond 18–24 months.

What is the difference between accelerated ageing and real-time ageing?

Real-time ageing stores the product at its intended storage conditions and monitors it over the full claimed shelf life period. Accelerated ageing compresses that timeline using elevated temperature. Real-time data is the gold standard for regulatory purposes; accelerated data is used to support timely product launch when the real-time study is still running.

Design your study with the right temperature, document your Ea assumption, and run your real-time study in parallel from Day 1. The accelerated data gets your product to market; the real-time data secures the expiry claim long term.